Paper32508641
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application.
Xie J and 6 others. Front Pharmacol, 2020. Cited by 354 papers, by iCite.
Cite this record
ConductScience Library. Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application. Papers, record 32508641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32508641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References174
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22409425 | Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. | ACS Nano | 2012 | https://conductscience.org/library/papers/22409425 | PubMed |
| 2 | 24733757 | Recombinant TAT-gelonin fusion toxin: synthesis and characterization of heparin/protamine-regulated cell transduction. | J Biomed Mater Res A | 2015 | https://conductscience.org/library/papers/24733757 | PubMed |
| 3 | 26722375 | Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3. | Theranostics | 2016 | https://conductscience.org/library/papers/26722375 | PubMed |
| 4 | 29777875 | Switching cell penetrating and CXCR4-binding activities of nanoscale-organized arginine-rich peptides. | Nanomedicine | 2018 | https://conductscience.org/library/papers/29777875 | PubMed |
| 5 | 25669902 | Poly-arginine and arginine-rich peptides are neuroprotective in stroke models. | J Cereb Blood Flow Metab | 2015 | https://conductscience.org/library/papers/25669902 | PubMed |
| 6 | 31083077 | Efficacy and Safety of AM-111 in the Treatment of Acute Unilateral Sudden Deafness-A Double-blind, Randomized, Placebo-controlled Phase 3 Study. | Otol Neurotol | 2019 | https://conductscience.org/library/papers/31083077 | PubMed |
| 7 | 15722168 | Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. | Adv Drug Deliv Rev | 2005 | https://conductscience.org/library/papers/15722168 | PubMed |
| 8 | 28126681 | Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy. | Colloids Surf B Biointerfaces | 2017 | https://conductscience.org/library/papers/28126681 | PubMed |
| 9 | 25112216 | Cell penetration: scope and limitations by the application of cell-penetrating peptides. | J Pept Sci | 2014 | https://conductscience.org/library/papers/25112216 | PubMed |
| 10 | 27411485 | Nanoparticles for Cancer Targeting: Current and Future Directions. | Curr Drug Deliv | 2016 | https://conductscience.org/library/papers/27411485 | PubMed |
| 11 | 29290795 | Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics. | Theranostics | 2018 | https://conductscience.org/library/papers/29290795 | PubMed |
| 12 | 27530388 | Functional peptides for siRNA delivery. | Adv Drug Deliv Rev | 2017 | https://conductscience.org/library/papers/27530388 | PubMed |
| 13 | 17943716 | Nanoplatforms for targeted molecular imaging in living subjects. | Small | 2007 | https://conductscience.org/library/papers/17943716 | PubMed |
| 14 | 29385037 | Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents. | Molecules | 2018 | https://conductscience.org/library/papers/29385037 | PubMed |
| 15 | 20338846 | Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37. | Biophys J | 2010 | https://conductscience.org/library/papers/20338846 | PubMed |
| 16 | 25335533 | Nanomedicine based on nucleic acids: pharmacokinetic and pharmacodynamic perspectives. | Curr Pharm Biotechnol | 2014 | https://conductscience.org/library/papers/25335533 | PubMed |
| 17 | 29949348 | Nanoparticle-Assisted Transcutaneous Delivery of a Signal Transducer and Activator of Transcription 3-Inhibiting Peptide Ameliorates Psoriasis-like Skin Inflammation. | ACS Nano | 2018 | https://conductscience.org/library/papers/29949348 | PubMed |
| 18 | 30972284 | Dual-targeting and microenvironment-responsive micelles as a gene delivery system to improve the sensitivity of glioma to radiotherapy. | Acta Pharm Sin B | 2019 | https://conductscience.org/library/papers/30972284 | PubMed |
| 19 | 17025271 | Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. | AAPS J | 2006 | https://conductscience.org/library/papers/17025271 | PubMed |
| 20 | 2849510 | Cellular uptake of the tat protein from human immunodeficiency virus. | Cell | 1988 | https://conductscience.org/library/papers/2849510 | PubMed |
Cited by237
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 354 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938774 | Cell-Penetration Peptide-Conjugated Octominin II Hybrid Inhibits the Multidrug-Resistant Shigella flexneri. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42938774 | PubMed |
| 42907643 | Analytical Insights and Biomedical Applications of Homing Penetrating Peptides in Cancer. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42907643 | PubMed |
| 42771317 | Cell-Penetrating Peptide Delivery for CRISPR Applications. | Methods Mol Biol | 2027 | https://conductscience.org/library/papers/42771317 | PubMed |
| 42719545 | Artificial intelligence-driven prediction and design of cell-penetrating peptides for advanced drug delivery system. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42719545 | PubMed |
| 42682974 | Host nucleolin-targeting unique peptide drugs as potent broad-spectrum anti-influenza therapies. | PNAS Nexus | 2026 | https://conductscience.org/library/papers/42682974 | PubMed |
| 42678616 | Non-Covalent Active Mixing as a Viable Alternative to Covalent Conjugation for the Intracellular Delivery of Biologics: The Case of Glucarpidase. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42678616 | PubMed |
| 42677397 | Protein Modifications for Cellular Protein Delivery. | Chem Rev | 2026 | https://conductscience.org/library/papers/42677397 | PubMed |
| 42645161 | Decoding Synaptic Diversity: Molecular Architectures, Phase Transitions, and Shared Postsynaptic Failure in Alzheimer's and Parkinson's Disease. | Cells | 2026 | https://conductscience.org/library/papers/42645161 | PubMed |
| 42635939 | Protein Kinase C-delta (PKCδ) in Neurodegeneration and Cerebral Ischemia: Molecular Mechanisms and Therapeutic Implications. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/42635939 | PubMed |
| 42624994 | Intracellular protein binders for imaging, control and future therapeutics. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/42624994 | PubMed |
| 42441732 | CPP2Vec: A representation learning approach for cell-penetrating peptides prediction. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42441732 | PubMed |
| 42394983 | Enhancing diabetes treatment by targeted nucleic acid and drug delivery using cell-penetrating peptides, peptide nucleic acids, and receptor targeting. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42394983 | PubMed |
| 42253304 | Bacterial Systems as a Precision Delivery Platform of Therapeutic Peptides for Cancer Therapy. | Polym Sci Technol | 2025 | https://conductscience.org/library/papers/42253304 | PubMed |
| 42250151 | Polyproline Modulates Membrane Translocation of Arginine-Rich Cell-Penetrating Peptides: Insights from Molecular Dynamics Simulations. | J Membr Biol | 2026 | https://conductscience.org/library/papers/42250151 | PubMed |
| 42233712 | Eye Drop Development of Anti-VEGF Therapeutics by Ocular Penetrating Carrier to the Posterior Region of the Eye. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/42233712 | PubMed |
| 42178594 | The transmembrane segments of SARS-CoV-2 nsp3 govern viral intracellular trafficking. | Cell Biosci | 2026 | https://conductscience.org/library/papers/42178594 | PubMed |
| 42129171 | Biomolecular Condensates as Protein Degradation Tools for Intracellular Targets. | Nat Commun | 2026 | https://conductscience.org/library/papers/42129171 | PubMed |
| 42109009 | Targeted drug delivery systems for cardiovascular disease treatment: principles, targeting strategies, and future prospects. | Ann Med | 2026 | https://conductscience.org/library/papers/42109009 | PubMed |
| 42072633 | Design of TAT-Conjugated Bowman-Birk Trypsin Inhibitor Peptides with Enhanced Antimicrobial and Antiproliferative Activities. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072633 | PubMed |
| 41942053 | Therapeutic peptides and proteins: Status and developments in drug delivery. | J Control Release | 2026 | https://conductscience.org/library/papers/41942053 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32508641
GET https://conductscience.org/api/papers/v1/32508641/references?page=2